The Potential Systemic Anti-Inflammatory Effect of Turmeric Dried Extract
Concetta Montanino1, Federica Farinella1, Bruna De Felice1
1Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania Luigi Vanvitelli, Caserta, 81100, Italy.
Endocrine, Metabolic & Immune Disorders Drug Targets
|January 10, 2025
Summary
This study compared two curcumin formulations for their anti-inflammatory and cholesterol-lowering effects. The water-soluble Curcuin showed significantly greater reductions in inflammatory markers and LDL cholesterol compared to the traditional fat-soluble curcumin.
Area of Science:
- Pharmacology
- Nutraceuticals
- Inflammation Research
Background:
- Curcumin, derived from turmeric, is known for its therapeutic potential but suffers from poor bioavailability.
- Strategies like piperine conjugation and phospholipid/liposomal complexes aim to enhance curcumin's absorption.
- This study investigates two distinct curcumin formulations: a traditional fat-soluble version and an innovative water-soluble micellar form (Curcuin).
Purpose of the Study:
- To compare the systemic anti-inflammatory effects of a standard 95% curcumin formulation with a novel water-soluble curcumin (Curcuin).
- To evaluate the impact of these formulations on key inflammatory and lipid biomarkers.
Main Methods:
- A study involving 30 patients divided into two groups.
- Group 1 received 425mg/day of 95% curcumin with piperine for 90 days.
- Group 2 received 100mg/day of standardized water-soluble curcumin (Curcuin) in a micellar aqueous solution.
Main Results:
- Both curcumin formulations led to decreased levels of Erythrocyte Sedimentation Rate (ESR), C-reactive protein (CRP), Ferritin, and LDL cholesterol.
- The Curcuin group demonstrated significantly greater reductions in these parameters compared to the 95% curcumin with piperine group.
- These findings indicate both anti-inflammatory and cholesterol-lowering actions for both formulations.
Conclusions:
- Both tested curcumin extracts effectively reduced inflammatory markers and LDL cholesterol.
- Curcuin, the water-soluble formulation, exhibited a more pronounced effect, suggesting its potential as a coadjuvant therapy.
- Further research is required to optimize curcumin dosage, form, and frequency for clinical application.
Related Concept Videos
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
95
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95
01:29Drugs for Treatment of Ulcerative Colitis in IBD
119
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
119